Form 4: Xtant Medical Holdings Executive Brandt Kevin D Reports Tax Withholding Share Transaction
SEC Form 4 Filing
Kevin D. Brandt, Chief Commercial Officer of Xtant Medical Holdings, reports a transaction involving the withholding of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On August 15, 2024, Kevin D. Brandt, the Chief Commercial Officer of Xtant Medical Holdings, Inc. had 56,333 shares of common stock withheld by the issuer to cover tax obligations.
- This transaction occurred due to the vesting and settlement of restricted stock unit awards.
- Following the transaction, Brandt directly owns 943,736 shares of Xtant Medical Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock-based awards, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the withholding of shares for tax purposes, which is a normal part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of the transaction where shares were withheld for tax obligations. |
| 08/19/2024 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.